The Emirates Drug Establishment has officially approved MIMRYLO (rusfertide), making the UAE the second nation in the world to authorize this breakthrough treatment for polycythemia vera. Designed to restrict excessive red blood cell production, MIMRYLO helps control blood viscosity and significantly lowers the risk of severe blood clots
UAE Approves MIMRYLO (Rusfertide) For Rare Blood Disorder
Leave a Reply